Daniel L. Schwartz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel L. Schwartz has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Edward A. Neuwelt
Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA
3 shared publications David L. Lahna
Oregon Health & Science University, Layton Aging and Alzheimer's Disease Center, Neurology, USA
2 shared publicationsDavid Lahna
Oregon Health & Science University Portland OR USA
2 shared publications- Leslie L. Muldoon
Department of Neurology, Oregon Health & Science University, Portland, OR, USA
2 shared publications Lisa C Silbert
Oregon Health & Science University Portland OR USA
2 shared publicationsNatalie E Roese
Oregon Health & Science University Portland OR USA
2 shared publications
Latest Publications
- Open Access
- 13 October 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 113, 1-5
Reduced total number of enlarged perivascular spaces in post-traumatic epilepsy patients with unilateral lesions – a feasibility study
- 13 October 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 113, 1-5
Open AccessReduced total number of enlarged perivascular spaces in post-traumatic epilepsy patients with unilateral lesions – a feasibility study
- 31 December 2021
- Published by Wiley in Alzheimer's & Dementia
- Vol. 17 (S1) , e056683
Age‐related ventricular expansion is not spatially concordant with MR‐visible periventricular white matter disease
Background: Ventricular expansion (VE) is recognized as one of the earliest predictors of Alzheimer’s disease (AD); however, VE is also ubiquitous in normal aging. VE is reportedly caused by an ex vacuo mechanism, whereby tissue that appears as periventricular white matter hyperintensity visible on FLAIR MRI (PVH) experiences white matter (WM) atrophy and is subsumed by the lateral ventricles. This longitudinal study sought to test the degree to which the locations into which the ventricles expand were previously PVH as opposed to other tissues.Method: Sixty‐five cognitively intact aged subjects each received 2‐6 T1‐weighted and FLAIR MRIs (Table 1). Each volume was rigidly coregistered to the baseline volume and gray matter (GM), lateral ventricular and PVH masks were generated for each timepoint. Ventricular growth masks (VG) were generated for each subsequent timepoint, each VG voxel was classified into either GM, PVH, or normal appearing white matter (NAWM) per overlap with previous timepoint tissue masks (Figure 1A).Result: Overall, average VE between visits was 5.1cm3. Over all subjects and visits, 4.2% of VE occurred where tissue had been previously marked as PVH, 16.1% of VE occurred where tissue had previously been marked as GM, including subcortical GM and the hippocampus, and 75.4% of VE occurred in tissue that had been previously marked as NAWM (Figure 1B).Conclusion: The results support an alternative explanation for VE; that is, that ex vacuo expansion of the lateral ventricles may not be the primary mechanism by which ventriculomegaly occurs in aging. One possible explanation is that unaltered CSF production in the face of dysfunctional CSF egress dynamics causes fluid stasis and reflux which increases pressure in the lateral ventricles.
- 31 December 2021
- Published by Wiley in Alzheimer's & Dementia
- Vol. 17 (S1) , e056683
Age‐related ventricular expansion is not spatially concordant with MR‐visible periventricular white matter disease
Background: Ventricular expansion (VE) is recognized as one of the earliest predictors of Alzheimer’s disease (AD); however, VE is also ubiquitous in normal aging. VE is reportedly caused by an ex vacuo mechanism, whereby tissue that appears as periventricular white matter hyperintensity visible on FLAIR MRI (PVH) experiences white matter (WM) atrophy and is subsumed by the lateral ventricles. This longitudinal study sought to test the degree to which the locations into which the ventricles expand were previously PVH as opposed to other tissues.Method: Sixty‐five cognitively intact aged subjects each received 2‐6 T1‐weighted and FLAIR MRIs (Table 1). Each volume was rigidly coregistered to the baseline volume and gray matter (GM), lateral ventricular and PVH masks were generated for each timepoint. Ventricular growth masks (VG) were generated for each subsequent timepoint, each VG voxel was classified into either GM, PVH, or normal appearing white matter (NAWM) per overlap with previous timepoint tissue masks (Figure 1A).Result: Overall, average VE between visits was 5.1cm3. Over all subjects and visits, 4.2% of VE occurred where tissue had been previously marked as PVH, 16.1% of VE occurred where tissue had previously been marked as GM, including subcortical GM and the hippocampus, and 75.4% of VE occurred in tissue that had been previously marked as NAWM (Figure 1B).Conclusion: The results support an alternative explanation for VE; that is, that ex vacuo expansion of the lateral ventricles may not be the primary mechanism by which ventriculomegaly occurs in aging. One possible explanation is that unaltered CSF production in the face of dysfunctional CSF egress dynamics causes fluid stasis and reflux which increases pressure in the lateral ventricles.
- 7 December 2020
- Published by Wiley in Alzheimer's & Dementia
- Vol. 16 (S4)
The regional and local relationships between amyloid and MRI‐visible perivascular spaces in white matter differ according to amyloid load: An ADNI study
Background: The relationship between amyloid (Aβ) production and clearance is disturbed in Alzheimer’s disease (AD). Evidence suggests that a decrease in clearance efficiency from cortical gray matter (GM) is relevant in late‐onset cases, a framework supported by findings of concomitant decreases in cerebrospinal fluid Aβ. A peri/paravascular bulk flow pathway for CSF and interstitial fluid in parenchyma, which transports solutes like Aβ, was identified in mammals more than 30 years ago; perivascular spaces (PVS) in white matter (WM) are part of this clearance system, and PVS dysfunction may be both a cause and effect of Aβ buildup in GM.Method: Florbetapir PET, T1, and FLAIR MRI datasets of 95 ADNI subjects were used. Amyloid positive subjects (Aβ+) were defined by ADNI PET thresholds. MRI‐visible PVS were segmented using an automated algorithm and each was manually inspected, resulting in 8,392 PVS; GM was divided into 34 parcels per hemisphere and underlying WM was assigned to a parcel (Figure 1A). After Muller‐Gartner partial volume correction, amyloid SUVR in each GM parcel and PVS density in its associated WM, as well as the amyloid load in juxta‐WM GM (jGM) nearest each confirmed PVS (Figure 1B), were used as variables to describe the regional and local relationships between amyloid and PVS, respectively.Result: Cohort‐wide amyloid load and PVS density varied widely across brain regions (Figure 2, middle row). Regional measurements of PVS and Aβ significantly correlated in Aβ+ subjects but not Aβ‐ (Figure 2, bottom). A pattern of decreasing amyloid load 1‐4mm away from the nearest jGM voxel was found in both Aβ+ and Aβ‐; amyloid burden in jGM near PVS was higher than non PVS‐associated jGM in Aβ+ but lower in Aβ‐ (Figure 3).Conclusion: The complicated relationship between WM PVS and amyloid in GM differs according to amyloid load. Regional results suggest that PVS density is higher in regions with higher amyloid load, but only in Aβ+ individuals. Locally, WM PVS can be conceptualized as the clogged drain of a catchment system in Aβ+ subjects but as a functioning clearance system in those with sub‐threshold amyloid burden.
- 7 December 2020
- Published by Wiley in Alzheimer's & Dementia
- Vol. 16 (S4)
The regional and local relationships between amyloid and MRI‐visible perivascular spaces in white matter differ according to amyloid load: An ADNI study
Background: The relationship between amyloid (Aβ) production and clearance is disturbed in Alzheimer’s disease (AD). Evidence suggests that a decrease in clearance efficiency from cortical gray matter (GM) is relevant in late‐onset cases, a framework supported by findings of concomitant decreases in cerebrospinal fluid Aβ. A peri/paravascular bulk flow pathway for CSF and interstitial fluid in parenchyma, which transports solutes like Aβ, was identified in mammals more than 30 years ago; perivascular spaces (PVS) in white matter (WM) are part of this clearance system, and PVS dysfunction may be both a cause and effect of Aβ buildup in GM.Method: Florbetapir PET, T1, and FLAIR MRI datasets of 95 ADNI subjects were used. Amyloid positive subjects (Aβ+) were defined by ADNI PET thresholds. MRI‐visible PVS were segmented using an automated algorithm and each was manually inspected, resulting in 8,392 PVS; GM was divided into 34 parcels per hemisphere and underlying WM was assigned to a parcel (Figure 1A). After Muller‐Gartner partial volume correction, amyloid SUVR in each GM parcel and PVS density in its associated WM, as well as the amyloid load in juxta‐WM GM (jGM) nearest each confirmed PVS (Figure 1B), were used as variables to describe the regional and local relationships between amyloid and PVS, respectively.Result: Cohort‐wide amyloid load and PVS density varied widely across brain regions (Figure 2, middle row). Regional measurements of PVS and Aβ significantly correlated in Aβ+ subjects but not Aβ‐ (Figure 2, bottom). A pattern of decreasing amyloid load 1‐4mm away from the nearest jGM voxel was found in both Aβ+ and Aβ‐; amyloid burden in jGM near PVS was higher than non PVS‐associated jGM in Aβ+ but lower in Aβ‐ (Figure 3).Conclusion: The complicated relationship between WM PVS and amyloid in GM differs according to amyloid load. Regional results suggest that PVS density is higher in regions with higher amyloid load, but only in Aβ+ individuals. Locally, WM PVS can be conceptualized as the clogged drain of a catchment system in Aβ+ subjects but as a functioning clearance system in those with sub‐threshold amyloid burden.
- 1 November 2019
- Published by Elsevier in NeuroImage
- Vol. 202, 116126
Autoidentification of perivascular spaces in white matter using clinical field strength T1 and FLAIR MR imaging
- 1 November 2019
- Published by Elsevier in NeuroImage
- Vol. 202, 116126
Autoidentification of perivascular spaces in white matter using clinical field strength T1 and FLAIR MR imaging
- 16 January 2019
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 50 (3) , 878-888
Multisite reliability and repeatability of an advanced brain MRI protocol
Background: MRI is the imaging modality of choice for diagnosis and intervention assessment in neurological disease. Its full potential has not been realized due in part to challenges in harmonizing advanced techniques across multiple sites.Purpose: To develop a method for the assessment of reliability and repeatability of advanced multisite‐multisession neuroimaging studies and specifically to assess the reliability of an advanced MRI protocol, including multiband fMRI and diffusion tensor MRI, in a multisite setting.Study Type: Prospective.Population: Twice repeated measurement of a single subject with stable relapsing‐remitting multiple sclerosis (MS) at seven institutions.Field Strength/Sequence: A 3 T MRI protocol included higher spatial resolution anatomical scans, a variable flip‐angle longitudinal relaxation rate constant (R1 ≡ 1/T1) measurement, quantitative magnetization transfer imaging, diffusion tensor imaging, and a resting‐state fMRI (rsFMRI) series.Assessment: Multiple methods of assessing intrasite repeatability and intersite reliability were evaluated for imaging metrics derived from each sequence.Statistical Tests: Student's t‐test, Pearson's r, and intraclass correlation coefficient (ICC) (2,1) were employed to assess repeatability and reliability. Two new statistical metrics are introduced that frame reliability and repeatability in the respective units of the measurements themselves.Results: Intrasite repeatability was excellent for quantitative R1, magnetization transfer ratio (MTR), and diffusion‐weighted imaging (DWI) based metrics (r > 0.95). rsFMRI metrics were less repeatable (r = 0.8). Intersite reliability was excellent for R1, MTR, and DWI (ICC >0.9), and moderate for rsFMRI metrics (ICC∼0.4).Data Conclusion: From most reliable to least, using a new reliability metric introduced here, MTR > R1 > DWI > rsFMRI; for repeatability, MTR > DWI > R1 > rsFMRI. A graphical method for at‐a‐glance assessment of reliability and repeatability, effect sizes, and outlier identification in multisite‐multisession neuroimaging studies is introduced.Level of Evidence: 1Technical Efficacy: Stage 2J. Magn. Reson. Imaging 2019;50:878–888.
- 16 January 2019
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 50 (3) , 878-888
Multisite reliability and repeatability of an advanced brain MRI protocol
Background: MRI is the imaging modality of choice for diagnosis and intervention assessment in neurological disease. Its full potential has not been realized due in part to challenges in harmonizing advanced techniques across multiple sites.Purpose: To develop a method for the assessment of reliability and repeatability of advanced multisite‐multisession neuroimaging studies and specifically to assess the reliability of an advanced MRI protocol, including multiband fMRI and diffusion tensor MRI, in a multisite setting.Study Type: Prospective.Population: Twice repeated measurement of a single subject with stable relapsing‐remitting multiple sclerosis (MS) at seven institutions.Field Strength/Sequence: A 3 T MRI protocol included higher spatial resolution anatomical scans, a variable flip‐angle longitudinal relaxation rate constant (R1 ≡ 1/T1) measurement, quantitative magnetization transfer imaging, diffusion tensor imaging, and a resting‐state fMRI (rsFMRI) series.Assessment: Multiple methods of assessing intrasite repeatability and intersite reliability were evaluated for imaging metrics derived from each sequence.Statistical Tests: Student's t‐test, Pearson's r, and intraclass correlation coefficient (ICC) (2,1) were employed to assess repeatability and reliability. Two new statistical metrics are introduced that frame reliability and repeatability in the respective units of the measurements themselves.Results: Intrasite repeatability was excellent for quantitative R1, magnetization transfer ratio (MTR), and diffusion‐weighted imaging (DWI) based metrics (r > 0.95). rsFMRI metrics were less repeatable (r = 0.8). Intersite reliability was excellent for R1, MTR, and DWI (ICC >0.9), and moderate for rsFMRI metrics (ICC∼0.4).Data Conclusion: From most reliable to least, using a new reliability metric introduced here, MTR > R1 > DWI > rsFMRI; for repeatability, MTR > DWI > R1 > rsFMRI. A graphical method for at‐a‐glance assessment of reliability and repeatability, effect sizes, and outlier identification in multisite‐multisession neuroimaging studies is introduced.Level of Evidence: 1Technical Efficacy: Stage 2J. Magn. Reson. Imaging 2019;50:878–888.
- Open Access
- 20 December 2016
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 13 (1) , 1-9
Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab
Neovascularization, a distinguishing trait of high-grade glioma, is a target for anti-angiogenic treatment with bevacizumab (BEV). This study sought to use ferumoxytol-based dynamic susceptibility contrast magnetic resonance imaging (MRI) to clarify perfusion and relative blood volume (rCBV) changes in glioma treated with BEV and to determine potential impact on clinical management. 16 high grade glioma patients who received BEV following post-chemoradiation radiographic or clinical progression were included. Ferumoxytol-based MRI perfusion measurements were taken before and after BEV. Lesions were defined at each timepoint by gadolinium-based contrast agent (GBCA)-enhancing area. Lesion volume and rCBV were compared pre and post-BEV in the lesion and rCBV “hot spot” (mean of the highest rCBV in a 1.08 cm2 area in the enhancing volume), as well as hypoperfused and hyperperfused subvolumes within the GBCA-enhancing lesion. GBCA-enhancing lesion volumes decreased 39% (P = 0.01) after BEV. Mean rCBV in post-BEV GBCA-enhancing area did not decrease significantly (P = 0.227) but significantly decreased in the hot spot (P = 0.046). Mean and hot spot rCBV decreased (P = 0.039 and 0.007) when post-BEV rCBV was calculated over the pre-BEV GBCA-enhancing area. Hypoperfused pixel count increased from 24% to 38 (P = 0.007) and hyperperfused decreased from 39 to 28% (P = 0.017). Mean rCBV decreased in 7/16 (44%) patients from >1.75 to <1.75, the cutoff for pseudoprogression diagnosis. Decreased perfusion after BEV significantly alters rCBV measurements when using ferumoxytol. BEV treatment response hinders efforts to differentiate true progression from pseudoprogression using blood volume measurements in malignant glioma, potentially impacting patient diagnosis and management.
- 20 December 2016
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 13 (1) , 1-9
Open AccessMisleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab
Neovascularization, a distinguishing trait of high-grade glioma, is a target for anti-angiogenic treatment with bevacizumab (BEV). This study sought to use ferumoxytol-based dynamic susceptibility contrast magnetic resonance imaging (MRI) to clarify perfusion and relative blood volume (rCBV) changes in glioma treated with BEV and to determine potential impact on clinical management. 16 high grade glioma patients who received BEV following post-chemoradiation radiographic or clinical progression were included. Ferumoxytol-based MRI perfusion measurements were taken before and after BEV. Lesions were defined at each timepoint by gadolinium-based contrast agent (GBCA)-enhancing area. Lesion volume and rCBV were compared pre and post-BEV in the lesion and rCBV “hot spot” (mean of the highest rCBV in a 1.08 cm2 area in the enhancing volume), as well as hypoperfused and hyperperfused subvolumes within the GBCA-enhancing lesion. GBCA-enhancing lesion volumes decreased 39% (P = 0.01) after BEV. Mean rCBV in post-BEV GBCA-enhancing area did not decrease significantly (P = 0.227) but significantly decreased in the hot spot (P = 0.046). Mean and hot spot rCBV decreased (P = 0.039 and 0.007) when post-BEV rCBV was calculated over the pre-BEV GBCA-enhancing area. Hypoperfused pixel count increased from 24% to 38 (P = 0.007) and hyperperfused decreased from 39 to 28% (P = 0.017). Mean rCBV decreased in 7/16 (44%) patients from >1.75 to <1.75, the cutoff for pseudoprogression diagnosis. Decreased perfusion after BEV significantly alters rCBV measurements when using ferumoxytol. BEV treatment response hinders efforts to differentiate true progression from pseudoprogression using blood volume measurements in malignant glioma, potentially impacting patient diagnosis and management.
- 9 April 2016
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 12 (6) , 1535-1542
Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific
- 9 April 2016
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 12 (6) , 1535-1542
Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific
- Open Access
- 17 February 2015
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 12 (1) , 5
Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis
Blockade of vascular endothelial growth factor (VEGF) to promote vascular normalization and inhibit angiogenesis has been proposed for the treatment of brain metastases; however, vascular normalization has not been well-characterized in this disease. We investigated the effect of treatment with bevacizumab anti-VEGF antibody on magnetic resonance imaging (MRI) biomarkers of brain tumor vascular characteristics in comparison to small molecule delivery in a rat model of human lung cancer brain metastasis.
- 17 February 2015
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 12 (1) , 5
Open AccessVascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis
Blockade of vascular endothelial growth factor (VEGF) to promote vascular normalization and inhibit angiogenesis has been proposed for the treatment of brain metastases; however, vascular normalization has not been well-characterized in this disease. We investigated the effect of treatment with bevacizumab anti-VEGF antibody on magnetic resonance imaging (MRI) biomarkers of brain tumor vascular characteristics in comparison to small molecule delivery in a rat model of human lung cancer brain metastasis.
- 1 May 2010
- Published by Elsevier in NeuroImage
- Vol. 50 (4) , 1392-1401
Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals
- 1 May 2010
- Published by Elsevier in NeuroImage
- Vol. 50 (4) , 1392-1401
Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals